Open Access
Subscription Access
Finding Achilles Heel of Drug Resistance in Mycobacterium tuberculosis
Tuberculosis (TB), a pulmonary disease caused by Mycobacterium tuberculosis is known to be the second largest cause of death and poses a serious threat to public health throughout the world. Although it can affect immunocompetent people, individuals with weakened immune system (e.g. HIV infection) are at an increased risk.
User
Font Size
Information
- Chandran, N., Ph D thesis, Academy of Scientific & Innovative Research, New Delhi, 2018.
- Kaur, D. et al., Sci. Rep., 2017, 7, 46595.
- Vashisht, R., J. Transl. Med., 2015, 13, 83.
- Kaur, D. et al., J. Transl. Med., 2018; 15(1), 261–277.
- Mishra, A. et al., EMBO Mol. Med., 2018, 10, e8038.
- Koul, A. et al., Nature Commun., 2014, 5(3369); doi:10.1038/ncomms4369.
- Xavier, S. A. and Lakshmanan, M., J. Pharmacol. Pharmacother., 2014, 5(3), 222–224.
- Chiang, C. Y., Van, D. A. and Rieder, H. L., Int. J. Tuberc. Lung Dis., 2016, 20(9), 1143–1147.
- Gillespie, S. H., Eur. Respir. Rev., 2016, 25(139), 19–28.
- Manjunatha, U., Boshoff, H. I. M. and Barry, C. E., Commun. Integr. Biol., 2009, 2(3), 215–218.
- Munsiff, S. S., Kambili, C. and Ahuja, S. D., Clin. Infect. Dis., 2006, 43(11), 1468–1475.
Abstract Views: 269
PDF Views: 82